title: [Oncogenes and anti-oncogenes in breast cancer].
abstract: Recent developments in molecular oncology have permitted the definition of alterations in proto-oncogenes (ras, myc, neu and hst/int.2) and anti-oncogenes (Rb.1) in human breast carcinomas. Detection of these abnormalities could be of prognostic interest. However, this remains controversial.
authors.affiliation: U.119, Marseille, France.
authors.forename: D
authors.initials: D
authors.lastname: Birnbaum
authors.forename: P
authors.initials: P
authors.lastname: Gaudray
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics*; D011905:Genes, ras / Q000235:genetics; D006801:Humans; D009857:Oncogenes / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics; D016271:Proto-Oncogene Proteins c-myc; D011519:Proto-Oncogenes / Q000235:genetics; D018719:Erb-b2 Receptor Tyrosine Kinases
chemical_list: D011518:Proto-Oncogene Proteins; D016271:Proto-Oncogene Proteins c-myc; D018719:Erb-b2 Receptor Tyrosine Kinases
vernacular_title: Les oncogènes et anti-oncogènes dans les cancers du sein.